CIK 0001070494
- Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 061376651
- Phone
- +1 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- 4 Option exercise Director acquired 16,862 shares (option exercise)
- 4 Grant or award Director acquired 26,608 shares (grant or award)
- 4 Open-market buy Director bought 896,522 shares at an average $25.33 ($22,707,098)
- 4 Open-market sale Principal Accounting Officer sold 5,947 shares at $22.50 ($133,808)
- 4 Open-market sale EVP, Chief Financial Officer sold 15,310 shares at $22.50 ($344,475)
- 4 Open-market sale EVP, COO, Head of Commercial sold 14,869 shares at $22.50 ($334,553)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale EVP,General Counsel, Secretary sold 917 shares at $21.18 ($19,422)
- 4 Open-market sale EVP, COO, Head of Commercial sold 548 shares at $21.18 ($11,607)
- 4 Open-market sale CEO sold 7,806 shares at $21.18 ($165,331)
- 4 Open-market sale Principal Accounting Officer sold 523 shares at $18.14 ($9,487)
- 4 Open-market sale EVP, COO, Head of Commercial sold 1,751 shares at $18.16 ($31,798)
- 4 Open-market sale Principal Accounting Officer sold 701 shares at $18.16 ($12,730)
- 4 Open-market sale EVP, Chief Financial Officer sold 1,916 shares at $18.16 ($34,795)
- 4 Open-market sale CEO sold 8,582 shares at $18.16 ($155,849)
- 4 Open-market sale EVP,General Counsel, Secretary sold 1,456 shares at $18.16 ($26,441)
Page 7 of 35 · 686 filings